{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T04:55:00Z","timestamp":1781758500681,"version":"3.54.5"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The purpose of this study was to investigate the clinical status of active monitoring [active surveillance (AS)] or surgical resection for adult low-risk papillary thyroid microcarcinoma (cT1aN0M0 PTMC) in the military and some local medical institutions in southern China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A questionnaire survey was conducted on the actual treatment mode of adult PTMC patients in the member institutions of the Southern Theater Command General Surgery Specialty Alliance. The respondents mainly included surgeons engaged in the surgical treatment of thyroid diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 36 medical institutions received replies, and the average annual volume of thyroid surgery in these institutions exceeded 100 cases. For suspicious nodules detected via ultrasound, routine fine-needle aspiration cytology (FNAC) for all suspicious nodules was recommended by six institutions (16.7%); nine (25.0%) performed FNAC only for nodules larger than 10 mm. After diagnosis, AS was recommended by six institutions (16.7%), immediate surgery was recommended by six institutions (16.7%), and 13 institutions (36.1%) left the treatment decision to the patient. For the AS protocol, 22 institutions recommended initial monitoring every 3 months, and 11 recommended every 6 months. When obvious clinical symptoms, new lymph node metastasis, or extrathyroidal invasion appeared, these institutions tended to convert from AS to surgery. During the continuous 3-month period selected by each institution from 2024 to 2025, among 474 PTMC patients, 228 (48.1%) underwent immediate surgery as initial treatment, 175 (36.9%) chose initial AS, and 63 (13.3%) received radiofrequency\/microwave ablation. Of the 175 patients initially managed with AS, 49 (28.0% of the AS group) subsequently underwent surgery. Correlation analysis showed that the number of patients undergoing surgery was significantly higher in general surgery departments and in institutions with a larger number of thyroid surgeons (p &amp;lt; 0.05). At the same time, the number of patients receiving AS was significantly higher in tertiary hospitals (p &amp;lt; 0.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Within our specialized alliance member institutions, more than one-third of low-risk PTMC patients have adopted AS as their management strategy. However, significant variability exists across medical institutions regarding the indications and implementation protocols for AS. To facilitate the broader and more standardized application of AS, it is essential to strengthen educational efforts directed at both clinicians and patients and to develop more refined, population-specific clinical guidelines or expert consensus for the management of low-risk PTMC in the Chinese population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1870202","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T04:36:18Z","timestamp":1781757378000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Active surveillance or surgical resection? A survey of treatment strategies for low-risk papillary thyroid microcarcinoma in adults"],"prefix":"10.3389","volume":"16","author":[{"given":"Xia","family":"Qin","sequence":"first","affiliation":[{"name":"Department of General Surgery, First Naval Hospital of Southern Command","place":["Zhanjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-tao","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, First Naval Hospital of Southern Command","place":["Zhanjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao-zhi","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of General Surgery, First Naval Hospital of Southern Command","place":["Zhanjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of General Surgery, First Naval Hospital of Southern Command","place":["Zhanjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-fa","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of General Surgery, First Naval Hospital of Southern Command","place":["Zhanjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14194712","article-title":"Association between obesity indexes and thyroid cancer risk in Korean women: nested case-control study","volume":"14","author":"Jang","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1461372","article-title":"A hybrid machine learning model combining association rule mining and classification algorithms to predict differentiated thyroid cancer recurrence","volume":"11","author":"Firat Atay","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-011-1663-x","article-title":"Incidental papillary microcarcinoma of the thyroid--further evidence of a very low Malignant potential: a retrospective clinicopathological study with up to 30 years of follow-up","volume":"18","author":"Neuhold","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.rceng.2019.12.012","article-title":"Papillary thyroid microcarcinoma with minimal extrathyroidal extension. Is its course so indolent that it requires a less aggressive treatment","volume":"221","author":"Ruiz Pardo","year":"2021","journal-title":"Rev Clin Esp (Barc)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1530\/eje-21-0256","article-title":"Management of endocrine disease: Papillary thyroid microcarcinoma: toward an active surveillance strategy","volume":"185","author":"Molinaro","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1089\/thy.2017.0227","article-title":"Insights into the management of papillary microcarcinoma of the thyroid","volume":"28","author":"Miyauchi","year":"2018","journal-title":"Thyroid"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3803\/enm.2021.1042","article-title":"Active surveillance as an effective management option for low-risk papillary thyroid microcarcinoma","volume":"36","author":"Jeon","year":"2021","journal-title":"Endocrinol Metab (Seoul)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1089\/thy.2019.0587","article-title":"From overdiagnosis to overtreatment of low-risk thyroid cancer: a thematic analysis of attitudes and beliefs of endocrinologists, surgeons, and patients","volume":"30","author":"Jensen","year":"2020","journal-title":"Thyroid"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2021.0713","article-title":"2021 Korean thyroid imaging reporting and data system and imaging-based management of thyroid nodules: Korean society of thyroid radiology consensus statement and recommendations","volume":"22","author":"Ha","year":"2021","journal-title":"Kor J Radiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2020.0330","article-title":"Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma: consensus statements from the Japan association of endocrine surgery task force on management for papillary thyroid microcarcinoma","volume":"31","author":"Sugitani","year":"2021","journal-title":"Thyroid"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4158\/ep-2020-0201","article-title":"Quality of life in patients with low-risk papillary thyroid microcarcinoma: active surveillance versus immediate surgery","volume":"26","author":"Nakamura","year":"2020","journal-title":"Endocr Pract"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2020.0845","article-title":"Active surveillance for papillary thyroid microcarcinoma in a population with restrictive diagnostic workup strategies","volume":"31","author":"Lon\u010dar","year":"2021","journal-title":"Thyroid"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2022.01.013","article-title":"Can active surveillance management be developed for patients with low-risk papillary thyroid microcarcinoma? a preliminary investigation in a Chinese population","volume":"28","author":"Liu","year":"2022","journal-title":"Endocr Pract"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.20945\/2359-4292-2023-0371","article-title":"Implementing active surveillance for low-risk thyroid carcinoma into clinical practice: collaborative recommendations for Latin America","volume":"68","author":"Sanabria","year":"2024","journal-title":"Arch Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2019.0420","article-title":"Patients' view on the management of papillary thyroid microcarcinoma: active surveillance or surgery","volume":"30","author":"Yoshida","year":"2020","journal-title":"Thyroid"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2021.0614","article-title":"Progression of low-risk papillary thyroid microcarcinoma during active surveillance: interim analysis of a multicenter prospective cohort study of active surveillance on papillary thyroid microcarcinoma in Korea","volume":"32","author":"Lee","year":"2022","journal-title":"Thyroid"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-009-0359-x","article-title":"Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes","volume":"34","author":"Sugitani","year":"2010","journal-title":"World J Surg"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1007\/s12672-025-02789-5","article-title":"Global research landscape on active surveillance for papillary thyroid microcarcinoma: a bibliometric analysis","volume":"16","author":"Kang","year":"2025","journal-title":"Discov Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0178","article-title":"A clinical framework to facilitate risk stratification when considering an active surveillance alternative to immediate biopsy and surgery in papillary microcarcinoma","volume":"26","author":"Brito","year":"2016","journal-title":"Thyroid"},{"key":"B21","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1186\/s12885-021-08230-8","article-title":"Active surveillance for thyroid cancer: a qualitative study of barriers and facilitators to implementation","volume":"21","author":"Jensen","year":"2021","journal-title":"BMC Cancer"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1870202\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T04:36:22Z","timestamp":1781757382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1870202\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":21,"alternative-id":["10.3389\/fonc.2026.1870202"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1870202","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"article-number":"1870202"}}